Back
Corvus Pharmaceuticals, Inc. Stock Predictions
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
65
CRVS
Corvus Pharmaceuticals, Inc.
Last Price:
$26.61
Seasonality Move:
-18%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Corvus Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Corvus Pharmaceuticals, Inc. has on average historically risen by 55.2% based on the past 9 years of stock performance.
-
Corvus Pharmaceuticals, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Corvus Pharmaceuticals, Inc. Stock Undervalued?The current Corvus Pharmaceuticals, Inc. [CRVS] share price is $25.52. The Score for CRVS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
CRVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Corvus Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Corvus Pharmaceuticals, Inc. has on average historically risen by 55.2% based on the past 9 years of stock performance.
Corvus Pharmaceuticals, Inc. Stock Rating
Buy
65
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Is Corvus Pharmaceuticals, Inc. overpriced?
-
Corvus Pharmaceuticals, Inc. has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Corvus Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com
52-Week Data
52-Week High:
26.22
52-Week Low:
2.54
Prediction Charts
Market Cap:
2B
Price in USD:
25.52
Volume:
12.8M
Beta:
1.23
Technical Analysis
SMA50:
8.90
SMA100:
7.81
SMA200:
5.89
52-Wk Change:
369.12%
Stock Predictions
-
Is Corvus Pharmaceuticals, Inc. stock public?Yes, Corvus Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Corvus Pharmaceuticals, Inc. stock quote today?The Corvus Pharmaceuticals, Inc. stock price is 25.52 USD today.
-
How to buy Corvus Pharmaceuticals, Inc. stock online?You can buy Corvus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-31 | 7.47 | 7.70 | 7.73 | 7.40 |
| Jan-5 | 7.25 | 6.79 | 7.36 | 6.73 |
| Jan-6 | 6.73 | 6.68 | 6.83 | 6.43 |
| Jan-7 | 6.73 | 7.10 | 7.18 | 6.68 |
| Jan-8 | 7.00 | 6.92 | 7.07 | 6.45 |
| Jan-9 | 6.90 | 6.79 | 7.00 | 6.66 |
| Jan-12 | 6.76 | 6.75 | 6.78 | 6.39 |
| Jan-13 | 6.66 | 6.50 | 6.74 | 6.46 |
| Jan-14 | 6.48 | 6.82 | 7.02 | 6.46 |
| Jan-15 | 6.83 | 7.14 | 7.22 | 6.74 |
| Jan-16 | 7.14 | 8.05 | 8.17 | 7.07 |
| Jan-20 | 13.51 | 21.41 | 22.10 | 12.69 |
| Jan-21 | 21.76 | 22.15 | 24.08 | 19.53 |
| Jan-22 | 24.30 | 25.52 | 26.22 | 23.76 |
Corvus Pharmaceuticals, Inc. Earnings
Corvus Pharmaceuticals, Inc. Earnings Report: Per Share Corvus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corvus Pharmaceuticals, Inc. Forecast Revenue Growth
Corvus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.03 per share.
* Corvus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.